Dysregulation of Macrophage Polarization is Associated with the Metastatic Process in Osteosarcoma
Overview
Authors
Affiliations
Osteosarcoma (OS) is the most common bone sarcoma in adolescents, and has poor prognosis. A vicious cycle is established between OS cells and their microenvironment in order to facilitate the tumor growth and cell spreading. The present work aims to better characterize the tumor microenvironment in OS in order to identify new therapeutic targets relating to metastatic process. Tissue microarrays of pre-chemotherapy OS biopsies were used for characterizing the tumor niche by immunohistochemistry. Parameters studies included: immune cells (M1, M2-subtypes of tumor-associated macrophages (TAM); T, B lymphocytes; mast cells), vascularization (endothelial, perivascular cells), OPG, RANKL, and mitotic index. Two groups of patients were defined, 22 localized OS (OS Meta-) and 28 metastatic OS (OS Meta+). The OS Meta- group was characterized by a higher infiltration of INOS+ M1-polarizedmacrophages and upregulated OPG immunostaining. OS Meta+ tumors showed a significant increase in CD146+ cells. INOS+ M1-macrophages were correlated with OPG staining, and negatively with the presence of metastases. CD163+ M2-macrophages were positively correlated with CD146+ cells. In multivariate analysis, INOS and OPG were predictive factors for metastasis. An older age, non-metastatic tumor, good response to chemotherapy, and higher macrophage infiltration were significantly associated with better overall survival. TAMs are associated with better overall survival and a dysregulation of M1/M2 polarized-macrophages in favor of M1 subtype was observed in non-metastatic OS.
Exosome tropism and various pathways in lung cancer metastasis.
Chen H, Liu L, Xing G, Zhang D, A N, Huang J Front Immunol. 2025; 16:1517495.
PMID: 40028322 PMC: 11868168. DOI: 10.3389/fimmu.2025.1517495.
Zhang L, Jiang H, Ma H Front Immunol. 2025; 16:1548527.
PMID: 39911380 PMC: 11794274. DOI: 10.3389/fimmu.2025.1548527.
Zhao S, Tian D, Huang F, Wang L, Cheng J, He Z Cancer Cell Int. 2025; 25(1):29.
PMID: 39885569 PMC: 11783933. DOI: 10.1186/s12935-025-03659-4.
Rodrigues J, Sarmento B, Leite Pereira C In Vitro Model. 2025; 1(1):5-27.
PMID: 39872973 PMC: 11756501. DOI: 10.1007/s44164-022-00008-x.
Oyama R, Nabeshima A, Endo M, Novikov A, Fujiwara T, Phelip C BJC Rep. 2025; 3(1):5.
PMID: 39870886 PMC: 11772650. DOI: 10.1038/s44276-024-00120-3.